Founded in 1999, Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer...
Founded in 1999, Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. Partnering of selected product candidates and technologies is a key focus of Genmab's strategy and the company has alliances with top tier pharmaceutical and biotechnology companies. Disclaimer: bit.ly/GENDisclaimer
Public Symbol
GEN
Founded Year
1999
Organization Website
genmab.com
Organization Languages
English
Organization Revenue
165300
Current Technologies
outlook
office 365
asp net
microsoft-iis
google analytics
omniture adobe
mobile friendly
vimeo
Job Functions
Information Technology
Finance
Education
Legal
Accounting
Operations
Human Resources
Media And Commmunication
Engineering
Business Development
Support
Administrative
biotechnology
health care
medical
health
wellness & fitness
A Sasser's Work History and Education
Genmab
Corporate Vice President, Head of Translational Research